Thiazide and Thiazide-Like Diuretics

Mga Pangunahing Punto

  • Ang thiazide at thiazide-like diuretics ay first-line antihypertensive agents at ginagamit din para sa edema treatment.
  • Hinaharang nila ang sodium-chloride reabsorption sa distal convoluted tubule at nagdudulot ng mild extracellular-fluid loss.
  • Kabilang sa class effect ang increased calcium reabsorption, na nagkakaiba sa kanila sa loop diuretics.
  • Mga pangunahing safety risks: hyponatremia, hypokalemia, metabolic alkalosis, hyperuricemia, hyperglycemia, at photosensitivity.
  • Mahahalagang interactions: lithium, digoxin-toxicity amplification dahil sa potassium loss, at NSAID-mediated effect attenuation.
  • Sa hyperparathyroid pathways, maaaring mabawasan ng thiazides ang urinary calcium loss kaya dapat i-interpret ang calcium at PTH trends sa tamang context.

Mechanism and Therapeutic Role

Hinaharang ng thiazide-class drugs ang Na-Cl transport sa distal nephron, kaya tumataas ang sodium/chloride excretion at kasunod na water loss. Dahil moderate ang natriuretic effect, madalas silang ipina-pair sa ibang antihypertensives o diuretic classes.

Pinapataas din ng mga gamot na ito ang calcium reabsorption at maaaring magpababa ng free-water loss sa selected contexts sa pamamagitan ng mild extracellular-volume contraction effects.

Drug Snapshot

DrugTypical Use PatternHigh-Yield RN Notes
HydrochlorothiazideHTN and edema dosing often starts low, then titratesCommon prototype thiazide; i-monitor ang sodium/potassium at BP response
ChlorothiazideIV pathways for edema contextsKapaki-pakinabang kapag limitado ang oral route
Metolazone (thiazide-like)Edema and HTN pathways, including CKD contextsMaaaring manatiling epektibo sa chronic renal disease at makapagpahusay ng loop-response sa diuretic resistance
Chlorthalidone (thiazide-like)HTN/edema with long duration (about 48-72 hours)Dahil matagal ang action, mas kailangan ang trend monitoring

Nursing Assessment

NCLEX Focus

I-prioritize ang potassium at sodium trend interpretation bago lumala tungo sa arrhythmia, panghihina, o neurologic change.

  • I-assess ang baseline at trend ng BP, HR, edema burden, urine output, at daily weight.
  • I-monitor ang electrolyte at metabolic labs: sodium, potassium, glucose, uric acid, at renal function.
  • I-monitor ang ECG rhythm at cardiac symptoms, lalo na kapag may hypokalemia risk.
  • I-screen ang contraindications/cautions: anuria, renal disease, sulfonamide sensitivity, at high-risk interaction profiles.
  • I-assess ang skin history at sunlight exposure patterns dahil sa photosensitivity/skin-risk concerns.

Nursing Interventions and Teaching

  • I-reassess ang therapeutic response gamit ang edema reduction at BP trend sa halip na single readings.
  • I-reinforce ang katamtamang potassium-rich intake kapag may potassium-wasting effects at wala namang ibang contraindication.
  • Turuan ang kliyente ng mahigpit na sun-protection behavior (sunscreen, protective clothing, exposure reduction).
  • Turuan ang kliyente na iwasan ang unsupervised NSAID use dahil maaari nitong pahinain ang diuretic-antihypertensive effectiveness.
  • I-reinforce ang agarang pag-report ng dizziness, panghihina, palpitations, decreased urine output, o mabilis na pagbabalik ng fluid retention.
  • Suportahan ang fluid-status documentation (daily weights, urine trend, dependent-edema checks) habang nasa active titration periods.

Digoxin-Toxicity Amplification

Ang thiazide-associated hypokalemia ay maaaring magpataas ng digoxin toxicity risk; agresibong i-monitor ang potassium sa combined therapy.

Lithium Interaction

Maaaring magpataas ng lithium levels ang thiazide diuretics; kailangan ng close level at toxicity monitoring sa combination therapy.

Photosensitivity Risk

Pinapataas ng thiazide pathways ang photosensitivity at maaaring magpataas ng skin-cancer risk sa chronic exposure.

Clinical Judgment Application

Clinical Scenario

Ang isang kliyenteng may chronic edema na naka-metolazone ay nag-ulat ng improved leg swelling pero may bagong generalized weakness at may potassium na 2.9 mEq/L sa follow-up labs.

  • Recognize Cues: Symptomatic improvement sa edema ngunit may makabuluhang pagbaba ng potassium.
  • Analyze Cues: Malamang na potassium-wasting adverse effect ito at may cardiac-risk potential na ngayon.
  • Prioritize Hypotheses: Pinakamataas na priority ang pag-iwas sa dysrhythmia at karagdagang electrolyte deterioration.
  • Generate Solutions: I-escalate ang lab finding, i-review ang interacting medications, at i-reinforce ang diet/supplement plan ayon sa order.
  • Take Action: I-implement ang potassium-correction at monitoring orders at ipagpatuloy ang fluid-status reassessment.
  • Evaluate Outcomes: Nagno-normalize ang potassium, bumubuti ang weakness, at nananatiling kontrolado ang edema.